Summit Investment Advisors »

Iovance Biotherapeutics shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $47k 22k 2.17
2025-06-30 $49k 29k 1.72
2025-03-31 $96k 29k 3.33
2024-12-31 $213k 29k 7.40
2024-09-30 $233k 25k 9.39
2024-06-30 $199k 25k 8.02
2024-03-31 $341k 23k 14.82
2023-12-31 $187k 23k 8.13
2023-09-30 $105k 23k 4.55
2023-06-30 $121k 17k 7.04
2023-03-31 $69k 11k 6.11
2022-12-31 $79k 11k 7.00
2022-09-30 $108k 11k 9.55
2022-06-30 $124k 11k 10.97
2020-03-31 $306k 10k 29.94
2019-12-31 $279k 10k 27.69
2019-09-30 $178k 9.8k 18.22
2019-06-30 $239k 9.8k 24.47
2019-03-31 $83k 8.8k 9.48
2018-12-31 $78k 8.8k 8.91
2018-09-30 $79k 7.0k 11.27
2018-06-30 $90k 7.0k 12.84
2018-03-31 $105k 6.2k 16.87
2017-12-31 $37k 4.6k 8.06
2017-09-30 $26k 4.6k 5.66
2017-06-30 $34k 4.6k 7.41